Loading…
Omnicell, Inc. is projected to rise to $50.17 by 2027, a +35% move from its current price of $37.11. OMCL is currently trading below its 50-day average (a bearish sign). Technical indicators currently lean strong sell.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 7/31/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Aug 1 | $35.98 | $37.14 | $38.33 | +0.07% |
| Aug 2 | $35.53 | $37.16 | $38.87 | +0.14% |
| Aug 3 | $35.20 | $37.19 | $39.29 | +0.22% |
| Aug 4 | $34.93 | $37.22 | $39.66 | +0.29% |
| Aug 5 | $34.69 | $37.24 | $39.98 | +0.36% |
| Aug 6 | $34.48 | $37.27 | $40.28 | +0.43% |
| Aug 7 | $34.29 | $37.30 | $40.57 | +0.51% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $34.29 | $37.30 | $40.57 | +0.51% |
| Week 2 | $33.29 | $37.49 | $42.21 | +1.01% |
| Week 3 | $32.57 | $37.68 | $43.58 | +1.52% |
| Week 4 | $32.01 | $37.87 | $44.79 | +2.04% |
| Week 5 | $31.54 | $38.06 | $45.92 | +2.55% |
| Week 6 | $31.14 | $38.25 | $46.99 | +3.07% |
| Week 7 | $30.78 | $38.44 | $48.01 | +3.59% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Omnicell, Inc. is a healthcare technology company operating in the United States and internationally. It provides hospital and health systems solutions, including Titan XT, an automated dispensing system; XTExtend, a console swap for its XT cabinets; and Central Pharmacy Dispensing Service for the medication dispensing process.
The company also offers Central Med Automation Service for medication dispensing; IV Compounding Service; specialty pharmacy services, including turnkey solutions to help health systems establish, manage, and optimize an entity-owned specialty pharmacy; EnlivenHealth platform to digitally enable retail and community pharmacies; medication adherence solutions comprising consumables and medication packaging systems; and related services to professional services and training. Omnicell, Inc. was incorporated in 1992 and is headquartered in Fort Worth, Texas.
It was formerly known as Omnicell Technologies, Inc. and changed its name to Omnicell, Inc. in 2001.
The stock trades under the symbol OMCL and sits within the Healthcare sector, reflecting its focus on healthcare technology solutions across markets.
Omnicell, Inc. (OMCL) is in the Healthcare sector with a current price of $37.11 and a market cap of $1.69B. It is ranked 2030 in market capitalization. The stock’s price now sits near a defined price level that anchors near-term support and context for longer-range forecasts.
The year-by-year forecast shows a pathway of rising averages and meaningful upside over time. The 2026 average is projected at $37.11, advancing to $60.28 on average by 2030 and reaching $296.26 on average by 2050, with the maximums climbing to $580.53 in 2050. Projected ROIs grow from 0% in 2026 to 62.4% by 2030 and up to 698.3% by 2050, with a bullish overall sentiment for the longer horizon.
A major floor 17.8% below — a decisive break under it would weaken the trend.
Price is testing support right now (0.0% away) — a key level to hold.
The nearest ceiling, 26.7% above — a clean break opens room to run.
A major ceiling 35.5% above — clearing it would confirm fresh momentum.
Key OMCL support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of OMCL market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $40.81 | Sell | $40.30 | Sell |
| MA 10 | $41.77 | Sell | $41.48 | Sell |
| MA 20 | $43.62 | Sell | $42.23 | Sell |
| MA 50 | $42.27 | Sell | $42.04 | Sell |
| MA 100 | $40.07 | Sell | $41.28 | Sell |
| MA 200 | $40.32 | Sell | $39.92 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 34.65 | Neutral |
| Stoch RSI (14) | 0.00 | Buy |
| CCI (20) | -189.13 | Sell |
| Williams %R (14) | -100.00 | Info |
| MACD (12,26,9) | -0.72 | Sell |
| ROC (12) | -19.22 | Sell |
| Bollinger %B (20,2) | -0.12 | Buy |
| Stochastic %K (14) | 0.00 | Buy |
| TRIX (15) | 0.09 | Buy |
| Awesome (5,34) | -1.13 | Sell |
| Ultimate (7,14,28) | 31.76 | Neutral |
| Momentum (10) | -9.89 | Sell |
| Aroon Osc (25) | -40.00 | Sell |
| Hull MA (9) | 40.62 | Sell |
| ADX (14) | 19.25 | Neutral |
| ATR (14) | 1.30 | Info |
The 30-day picture is NEUTRAL, with RSI(14) at 30. The near-term trend is balanced as investors assess the stock within its defined range.
SMA50 is $42.27 and SMA200 is $40.32, creating a cross of short-term moving averages around the current price. Support is listed at $37.11 and resistance at $47.00, framing a near-term trading band. The 30-day price range runs from $30.10 to $45.75, highlighting notable volatility within the month.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $32.35 | $37.11 | $52.36 | 0% | Neutral | |
| $39.42 | $50.17 | $67.87 | +35% | Bullish | |
| $43.42 | $57.14 | $80.68 | +54% | Bullish | |
| $42.76 | $57.86 | $84.43 | +56% | Bullish | |
| $43.47 | $60.28 | $90.43 | +62% | Bullish | |
| $47.06 | $66.73 | $102.55 | +80% | Bullish | |
| $54.84 | $79.40 | $124.67 | +114% | Bullish | |
| $67.19 | $99.23 | $158.84 | +167% | Bullish | |
| $67.21 | $101.13 | $164.80 | +173% | Bullish | |
| $65.22 | $99.91 | $165.51 | +169% | Bullish | |
| $98.33 | $163.56 | $290.22 | +341% | Bullish | |
| $154.11 | $296.26 | $580.53 | +698% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| July 2026 | $32.35 | $37.11 | $43.31 | +0.00% |
| August 2026 | $31.88 | $37.55 | $45.35 | +1.18% |
| September 2026 | $33.32 | $39.63 | $48.61 | +5.55% |
| October 2026 | $34.15 | $40.93 | $50.81 | +3.27% |
| November 2026 | $33.55 | $40.47 | $50.74 | -1.12% |
| December 2026 | $34.11 | $41.39 | $52.36 | +2.28% |
Click any year to see its month-by-month OMCL forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
The OMCL price prediction for 2026 points to an average of $37.11 (low $32.35, high $52.36) — a potential gain of 0% on today's $37.11. Price action looks broadly range-bound.
In 2027, OMCL is projected to trade between $39.42 and $67.87, averaging $50.17 — a potential gain of +35% from today's $37.11. That is up +35% on the projected 2026 average. Buyers look set to stay in control over this stretch.
Omnicell, Inc.'s 2028 outlook centres on $57.14, within a $43.42 to $80.68 range. That is up +14% on the projected 2027 average. That marks a +54% change versus current levels. Momentum favours further upside here.
By 2029, OMCL could reach as high as $84.43, with a base case around $57.86 and support toward $42.76 — roughly +56% from $37.11. Buyers look set to stay in control over this stretch.
Expect OMCL to range from $43.47 to $90.43 through 2030. The $60.28 average target implies a +62% move from current prices. That is up +4% on the projected 2029 average. Momentum favours further upside here.
The OMCL price prediction for 2031 points to an average of $66.73 (low $47.06, high $102.55) — a potential gain of +80% on today's $37.11. Buyers look set to stay in control over this stretch.
In 2032, OMCL is projected to trade between $54.84 and $124.67, averaging $79.40 — a potential gain of +114% from today's $37.11. That is up +19% on the projected 2031 average. Momentum favours further upside here.
Omnicell, Inc.'s 2033 outlook centres on $99.23, within a $67.19 to $158.84 range. That is up +25% on the projected 2032 average. That marks a +167% change versus current levels. Buyers look set to stay in control over this stretch.
By 2034, OMCL could reach as high as $164.80, with a base case around $101.13 and support toward $67.21 — roughly +173% from $37.11. Momentum favours further upside here.
Expect OMCL to range from $65.22 to $165.51 through 2035. The $99.91 average target implies a +169% move from current prices. That is -1% versus the projected 2034 average. Buyers look set to stay in control over this stretch.
The OMCL price prediction for 2040 points to an average of $163.56 (low $98.33, high $290.22) — a potential gain of +341% on today's $37.11. Momentum favours further upside here.
In 2050, OMCL is projected to trade between $154.11 and $580.53, averaging $296.26 — a potential gain of +698% from today's $37.11. That is up +81% on the projected 2040 average. Buyers look set to stay in control over this stretch.
Investing $1,000 in OMCL today (≈ 26.946915 OMCL) could be worth
$7,983.18
+$6,983.18 (+698%) by 2050 · US Dollar
Based on the average projected OMCL price of $296.26 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in OMCLwould be worth at today's price.
$1,000 invested in OMCL on Jul 30, 2025 (≈ 33.670033 OMCL) would be worth
$1,249.49
+$249.49 (+24.9%) today · 1.25× · US Dollar
Based on a OMCL entry price of $29.7 vs. today's $37.11.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $39.86 | $931.01 | -6.9% |
| 1 month ago | $41.52 | $893.79 | -10.6% |
| 3 months ago | $42.8 | $867.06 | -13.3% |
| 6 months ago | $48.5 | $765.15 | -23.5% |
| 1 year ago | $29.7 | $1,249.49 | +24.9% |
| All time (5.0y) ago | $146.3 | $253.66 | -74.6% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our OMCL forecast.
Our base-case forecast reaches $74.00 around 2032.
Implied market cap at $74.00: $3.37B
The multi-year outlook shows a steady uptrend in average prices and expanding upside through 2050. In 2026, the min is $32.35, the average is $37.11, and the max is $52.36, with an ROI of 0% for that year. By 2030, the average price is $60.28 and the ROI stands at 62.4%, indicating meaningful long-run upside despite the short-term volatility.
From 2031 onward, the forecast continues to show bullish momentum, with 2031 at $66.73 (ROI 79.8%), 2032 at $79.40 (ROI 114%), 2033 at $99.23 (ROI 167.4%), 2034 at $101.13 (ROI 172.5%), and 2035 at $99.91 (ROI 169.2%). By 2040, the average rises to $163.56 (ROI 340.7%), and by 2050 the average is $296.26 (ROI 698.3%), with a maximum forecast of $580.53. The sentiment remains BULLISH across the longer horizon, though these are projections, not guarantees, and depend on future conditions.
Tap a question to reveal the answer.
The 2030 forecast shows an average price of $60.28, with a minimum of $43.47 and a maximum of $90.43. The projected ROI is 62.4%, and the sentiment is BULLISH.
The forecasts depict a bullish trajectory beyond 2026, with 2027 average $50.17 (ROI 35.2%), 2028 average $57.14 (ROI 54%), 2029 average $57.86 (ROI 55.9%), and 2030 average $60.28 (ROI 62.4%).
Yes. The forecast max prices reach above $100 by 2033 ($158.84) and 2034 ($164.80), indicating the potential to exceed $100 in the outlook.
The 2050 forecast shows an average price of $296.26 and a maximum of $580.53, with a projected ROI of 698.3% and a bullish sentiment.
Omnicell, Inc. Community Discussion
0Share your Omnicell, Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.